Related Experiment Video
Updated: Nov 6, 2025
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy
Shimpei Anami1, Junya Fukai2, Mizuki Hama3
1Department of Radiology, Wakayama Medical University, Wakayama, Japan; anami131@wakayama-med.ac.jp.
Background/Aim:
High-grade gliomas have a poor prognosis despite standard treatment. The aim of the study was to identify new prognostic factors to select patients who need more intense treatment.
Patients And Methods:
Forty-three consecutive patients underwent surgery plus chemoradiotherapy for pathologically diagnosed high-grade gliomas (grade III, IV).
Results:
The median survival time was 989 days, and the 1-year survival rate was 87.6%. Among patients with grade IV disease, the median survival time, 1-year, and 2-year survival rate were 814 days, 82.6%, and 58.7%, respectively. In the univariate analysis, unmethylated MGMT promoter (p=0.0495), brainstem infiltration (p=0.0004), basal ganglia as the primary lesion site (p=0.0056), 3-dimensional conformal radiotherapy (p=0.0286), and <50 Gy (p=0.0049) were associated with a poor prognosis. In the multivariate analysis, only brainstem infiltration retained significance (HR for death, 0.21; 95% CI=0.06-0.70; p=0.011).
Conclusion:
Brainstem infiltration is a novel prognostic factor for poor prognosis in patients with high-grade gliomas.
